|
1 Presentation of the Manuscript
1.1 Structure of the manuscript
Cover page (must be submitted as a supplementary file through the online
submission system) which should contain only:
- Title of the manuscript in English.
- Names of the authors in direct order with their respective degrees
and affiliations in English.
- Full address of the corresponding author, to whom all correspondence
should be addressed, including fax and phone number as well as e-mail
address.
1.2 Text
- The paper must be previously translated or reviewed by professional
or company responsible for English language. The costs of this service
will be under the authors responsibility. Authors with English
as native language must submit as supplementary file a signed letter
taking responsibility for the quality of the English language and
editing of the text.
- Title of the manuscript and subtitle, if necessary, in English.
- Abstract: should comprise at most 300 words, highlighting a little
introduction, objective, material and methods, results and conclusions.
- Key words: (words or expressions that identify the contents of
the manuscript). The authors are referred to the list of subjects
of the "lndex Medicus" and DeCS (Health Sciences Descriptors
available at http://decs.bvs.br/I/homepagei.htm/).
Authors must use periods to separate the key words, which must have
the first letter of the first word in capital letters. Ex: Dental
implants. Fixed prosthesis. Photoelasticity. Passive fit.
- Introduction: summary of the rationale and proposal of the study
including only proper references. It should clearly state the hypothesis
of the study.
- Material and Methods: the material and the methods are presented
with enough detail to allow confirmation of the findings. Include
city, state and country of all manufacturers right after the first
appearance of the products, reagents or equipments. Published methods
should be referred to and briefly discussed, except if modifications
were made. Indicate the statistical methods employed, if applicable.
Please refer to item 3 for ethical principals and registration of
clinical trials.
- Results: presents the outcomes in a logical sequence in the text,
tables and illustrations. Data contained in tables and illustrations
should not be repeated in the text, and only important findings should
be highlighted.
- Discussion: this should emphasize the new and important aspects
of the study and the resulting conclusions. Any data or information
mentioned in the introduction or results should not be repeated. Findings
of other important studies should be reported. The authors should
point out the implications of their findings as well as their limitations.
- Conclusion(s) (if any).
- Acknowledgments (when appropriate). Acknowledge those who have
contributed to the work. Specify sponsors, grants, scholarships and
fellowships with respective names and identification numbers.
- References (please refer to item 2.3)
2 TECHNICAL NORMALIZATION
The manuscript should be typed as follows: 1.5 spacing in 11 pt Arial
font, with 3-cm margins at each side, on an A4 page, adding up to at most
15 pages, including the illustrations (graphs, photographs, tables, etc).
The authors should keep a copy of the manuscript for possible requests.
2.1 Illustrations and Tables
2.1.1 The illustrations (photographs, graphs, drawings, charts, etc.),
regarded as figures, should be limited to the least amount possible
and should be uploaded in separate files, consecutively numbered with
Arabic numbers according to the order they appear in the text.
2.1.2 Photographs should be sent in original colors and digitized
in .jpg or tif formats with at least 10 cm width and at least 300
dpi. These illustrations should be provided in supplementary files
and not inserted in the Word document.
2.1.3 The corresponding legends for figures should be clear, concise
and typed at the end of the manuscript as a separate list preceded
by the corresponding number.
2.1.4 The tables should be logically arranged, consecutively numbered
with Arabic numbers. The legend shall be placed on the top of the
tables. Tables should be open in the right and left laterals.
2.1.5 Footnotes should be indicated by asterisks and restricted to
the least amount possible.
2.2 Citation of the Authors
Citation of the authors in the text may be performed in two manners:
1) Just numeric: " and interfere with the bacterial system and
tissue system 3,4,7-10". References must be cited in a numeric
ascending order within the paragraph.
2) or alphanumeric
- one author - Silva23 (1986)
- two authors - Silva and Carvalho25 (1987)
- three authors - Ferreira, Silva and Martins27 (1987)
- more than three authors- Silva, et al.28 (1988)
- Punctuation characters such as periods and commas must be placed
after the numeric citation of the authors. Ex: Ferreira38.
2.3 References
The references must follow the "Uniform requirements for manuscripts
submitted to Biomedical Journals - Vancouver" available at:
http://www.nlm.nih.gov/bsd/uniform_requirements.html.
2.3.1 All references must be cited in the text. They should be alphabetically
ordered by the last name of the author and numbered in increasing
order accordingly. The order of citation in the text should follow
these numbers. Abbreviations of the titles of the international journals
cited should follow the Index Medicus/MEDLINE.
2.3.2 Personal communications and unpublished data with no publication
date must not be included in the reference list.
2.3.3 Abstracts, monographs, dissertations and theses will not be
accepted as references.
2.3.4 The names of all authors should be cited up to 6 authors; in
case there are more authors, the 6 first authors should be cited,
followed by the expression ", et al.", which must be followed
by "period" and should not be written in italics. Ex: Uhl,
et al.
2.3.5 At most 30 references may be cited, except for invited reviews
by the Editor-in-Chief.
Examples of references:
Book
Melberg JR, Ripa LW, Leske GS. Fluoride in preventive dentistry:
theory and clinical applications. Chicago: Quintessence; 1983.
Book chapter
Verbeeck RMH. Minerals in human enamel and dentin. ln: Driessens
FCM, Woltgens JHM, editors. Tooth development and caries. Boca Raton
: CRC Press; 1986. p.95-152.
Papers published in journals
Wenzel A, Fejerskov O. Validity of diagnosis of questionable caries
lesions in occlusal surfaces of extracted third molars. Caries Res.
1992;26:188-93.
Papers with more than 6 authors
The first 6 authors are cited, followed by the expression ",
et al."
Parkin DM, Clayton D, Black RJ, Masuyer E, Friedl HP, Ivanov E,
et al. Childhood - leukemia in Europe after Chernobyl : 5 years
follow-up. Br J Cancer. 1996;73:1006-12.
Papers without authors names
Seeing nature through the lens of gender. Science. 1993;260:428-9.
Volume with supplement and/or Special Issue
Davisdson CL. Advances in glass-ionomer cements. J Appl Oral Sci.
2006;14(sp. Issue):3-9.
Entire issue
Dental Update. Guildford 1991;18(1).
The authors are fully responsible for the correctness of the references.
3 ETHICAL PRINCIPLES AND REGISTRATION OF CLINICAL TRIALS
3.1 Experimental procedures in humans and animals
The Journal of Applied Oral Science reassures the principles incorporated
in the Helsinky Declaration and insists that all research involving
human beings, in the event of publication in this journal, be conducted
in conformity with such principles and others specified in the respective
ethics committees of authors institution. In the case of experiments
with animals, such ethical principles must also be followed. When surgical
procedures in animals were used, the authors should present, in the
Material and Methods section, evidence that the dose of a proper substance
was adequate to produce anesthesia during the entire surgical procedure.
All experiments conducted in human or animals must accompany a description,
in the Material and Methods section, that the study was approved by
the respective Ethics Committee of authors affiliation and provide
the number of the protocol approval.
3.1.1 Papers presenting clinical trials or clinical studies
in human volunteers or in animals must contain the Ethical Committee
approval of the reports of the results presented for publication
as mandatory supplementary file.
3.2 Clinical Trial Registration - International Standard Randomized
Controlled Trial Number (ISRCTN)
The Journal of Applied Oral Science supports the policies of the World
Health Organization (WHO) and the International Committee of Medical
Journal Editors (ICMJE) for the registration of clinical trials. The
journal recognizes the importance of such initiatives for the registration
and international publication of clinical studies with an open access.
Therefore, the Journal of Applied Oral Science will publish only those
clinical trials that have previously received an identification number,
the ISRCTN, validated by the criteria established by the WHO and ICMJE.
The WHO defines clinical trials as "any research study that prospectively
assigns human participants or groups of humans to one or more health-related
interventions to evaluate the effects on health outcomes. Interventions
include but are not restricted to drugs, cells and other biological
products, surgical procedures, radiologic procedures, devices, behavioral
treatments, process-of-care changes, preventive care, etc".
3.2.1 Manuscripts presenting clinical trials in human volunteers
must be submitted with the following mandatory supplementary files:
3.3 The Editor-in-Chief and the Editorial Board reserve the right to
refuse manuscripts that show no clear evidence that the methods used
were not appropriate for experiments in humans or animals.
4 ANY QUERIES SHALL BE SOLVED BY THE Editor-in-Chief AND EDITORIAL
BOARD
|
|